PLAB Insider Sale: Christopher Progler Sells 10,000 Shares, Holds 200,591
Rhea-AI Filing Summary
Christopher J. Progler, EVP and Chief Technology Officer of Photronics Inc. (PLAB), reported the sale of 10,000 shares of the issuer's common stock on 09/02/2025 at a weighted average price of $21.93 per share. After the sale, Mr. Progler beneficially owns 200,591 shares. The filing states the transaction was executed under a Rule 10b5-1 trading plan adopted on December 22, 2024, and prices on the multiple trades ranged from $21.77 to $22.12. The Form 4 was signed by an attorney-in-fact on 09/04/2025.
Positive
- Transaction disclosed under a Rule 10b5-1 trading plan adopted on December 22, 2024, indicating a prearranged sale
- Full disclosure of trade details: transaction date, weighted average price, price range, and post-transaction holdings are reported
Negative
- Disposition of 10,000 shares on 09/02/2025 at a weighted average price of $21.93
- Beneficial ownership reduced to 200,591 shares following the reported sale
Insights
TL;DR: Insider sale of 10,000 shares under a pre-established 10b5-1 plan; reduces beneficial holdings to 200,591 shares.
The reported transaction is a routine disposition executed pursuant to a Rule 10b5-1 trading plan, which indicates the sale was pre-planned and not a spontaneous insider trade. The weighted average price of $21.93 and the disclosed price range provide transparency on execution levels. For investors, this is a clear disclosure of insider liquidity but, standing alone, does not reveal material changes to company operations or governance.
TL;DR: Filing shows compliance with Section 16 reporting and use of a 10b5-1 plan; signature executed by attorney-in-fact.
The Form 4 contains the necessary disclosures: transaction date, number of shares sold, price range, residual ownership, and the existence and adoption date of the 10b5-1 plan. The signature by an attorney-in-fact is properly indicated. This filing fulfills routine governance and disclosure obligations without presenting additional material corporate developments.
FAQ
Who reported the transaction on Form 4 for PLAB?
What shares were sold and when according to the Form 4?
At what price were the PLAB shares sold?
How many PLAB shares does the insider own after the sale?
Was the sale executed under a trading plan?
Who signed the Form 4 and when?